GLP-1 drugs show early signs of slowing biological ageing, but proof remains elusive

Preliminary analyses from Novo Nordisk, Eli Lilly and a University of California San Diego trial suggest popular diabetes and weight-loss medicines may affect biological-ageing markers, though they have not been shown to extend life. Early company-backed analyses suggest that widely…













